HTTP 200 OK
Allow: GET
Content-Type: application/json
Vary: Accept
{
"url": "https://lda.senate.gov/api/v1/filings/130a7604-c528-4781-a842-0ec1d47e1422/?format=api",
"filing_uuid": "130a7604-c528-4781-a842-0ec1d47e1422",
"filing_type": "Q2",
"filing_type_display": "2nd Quarter - Report",
"filing_year": 2021,
"filing_period": "second_quarter",
"filing_period_display": "2nd Quarter (Apr 1 - June 30)",
"filing_document_url": "https://lda.senate.gov/filings/public/filing/130a7604-c528-4781-a842-0ec1d47e1422/print/",
"filing_document_content_type": "text/html",
"income": null,
"expenses": "110000.00",
"expenses_method": "a",
"expenses_method_display": "Method A - Reporting amounts using LDA definitions only",
"posted_by_name": "Anna Jones",
"dt_posted": "2021-07-20T11:38:10.457000-04:00",
"termination_date": null,
"registrant_country": "United States of America",
"registrant_ppb_country": null,
"registrant_address_1": "5980 Horton Street",
"registrant_address_2": "Suite 105",
"registrant_different_address": false,
"registrant_city": "Emeryville",
"registrant_state": "CA",
"registrant_zip": "94608",
"registrant": {
"id": 401106060,
"url": "https://lda.senate.gov/api/v1/registrants/401106060/?format=api",
"house_registrant_id": null,
"name": "ZYMERGEN INC.",
"description": "Biofacturing company",
"address_1": "5980 Horton Street",
"address_2": "Suite 105",
"address_3": null,
"address_4": null,
"city": "Emeryville",
"state": "CA",
"state_display": "California",
"zip": "94608",
"country": "US",
"country_display": "United States of America",
"ppb_country": "US",
"ppb_country_display": "United States of America",
"contact_name": "MINA KIM",
"contact_telephone": "+1 415-706-0229",
"dt_updated": "2022-04-06T16:07:19.567075-04:00"
},
"client": {
"id": 210500,
"url": "https://lda.senate.gov/api/v1/clients/210500/?format=api",
"client_id": 12,
"name": "ZYMERGEN INC.",
"general_description": null,
"client_government_entity": false,
"client_self_select": true,
"state": "CA",
"state_display": "California",
"country": "US",
"country_display": "United States of America",
"ppb_state": "CA",
"ppb_state_display": "California",
"ppb_country": "US",
"ppb_country_display": "United States of America",
"effective_date": "2021-03-23"
},
"lobbying_activities": [
{
"general_issue_code": "MAN",
"general_issue_code_display": "Manufacturing",
"description": "Issues related to domestic biomanufacturing investment; pharmaceutical supply chain resilience; nominations; biomedicine, biotech, and the bioeconomy",
"foreign_entity_issues": "Foreign entities identified on form LD-1 have an interest in the lobbying issues.",
"lobbyists": [
{
"lobbyist": {
"id": 101171,
"prefix": null,
"prefix_display": null,
"first_name": "ANNA",
"nickname": null,
"middle_name": null,
"last_name": "JONES",
"suffix": null,
"suffix_display": null
},
"covered_position": null,
"new": false
}
],
"government_entities": [
{
"id": 11,
"name": "Executive Office of the President (EOP)"
},
{
"id": 2,
"name": "HOUSE OF REPRESENTATIVES"
},
{
"id": 21,
"name": "Office of Science & Technology Policy (OSTP)"
},
{
"id": 1,
"name": "SENATE"
}
]
}
],
"conviction_disclosures": [],
"foreign_entities": [],
"affiliated_organizations": []
}